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Abstract  20 
Objective: To investigate feasibility and acceptability of self-testing for proteinuria during pregnancy. 21 
Study Design: Mixed methods approach which included: an accuracy study where pregnant women 22 
(n=100) and healthcare professionals (n=96) tested seven synthetic protein samples and completed 23 
a questionnaire, a feasibility study where pregnant women who were self-monitoring their blood 24 
pressure were asked to self-test for proteinuria (n=30), and an online questionnaire about women’s 25 
experiences of self-testing (n=200). 26 
Main outcome measures: Sensitivity and specificity of testing and questionnaire results. 27 
Results: There were no significant differences in the accuracy of synthetic sample testing by 28 
pregnant women (sensitivity 0.81 (95% confidence intervals (CI) 0.78-0.85), specificity 0.93 (95% CI 29 
0.91-0.95) and healthcare professionals: (sensitivity 0.83 (95% CI 0.79-0.86), specificity 0.92 (95% CI 30 
0.90-0.94)). Automated readers had significantly better sensitivity (0.94 (0.91-0.97) (p≤ 0.001 in each 31 
case), but worse specificity 0.78 (0.69-0.85). Similar results were gained using self-tested urine 32 
samples compared to staff-testing using a reference standard of laboratory urine protein-creatinine 33 
ratio (uPCR). Women who completed the online survey with experience of self-testing (n=39, 20%) 34 
generally found it easy, and with support from healthcare professionals felt it improved involvement 35 
in their care and reduced anxiety.  36 
Conclusions: Self-testing for proteinuria by pregnant women had similar accuracy to healthcare 37 
professional testing and was acceptable to both groups. Self-testing of urine combined with self-38 
monitoring of blood pressure could provide a useful adjunct to clinic-based surveillance for the 39 
detection of pre-eclampsia. Such novel strategies warrant further research. 40 
 41 
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Introduction 45 
Apart from blood pressure measurement, urinalysis for protein is the most commonly performed 46 
antenatal screening test and is central to pre-eclampsia diagnosis.(1) The development of 47 
proteinuria in a hypertensive pregnancy is an important feature of multi-organ involvement.(2) 48 
Urine testing is routinely carried out by midwives, obstetricians or family physicians at antenatal 49 
visits.(1) Urinalysis reagent strips (dipsticks) are widely commercially available, inexpensive, 50 
convenient, and provide a rapid result.(4) Such testing strips are examined with automated readers 51 
or by visual inspection, the latter still commonplace out of hospital settings, where automated 52 
readers are seldom available. If positive results are found, then further testing, using spot urine 53 
protein: creatinine ratio (uPCR) or 24-hour sample analysis, is undertaken.(5) 54 
 55 
Confidential enquiries into maternal deaths in the United Kingdom report that women can develop 56 
pre-eclampsia between antenatal visits; and reiterate the importance of blood pressure and 57 
proteinuria testing at every opportunity.(6, 7) Urine self-testing in pregnancy is widely acceptable for 58 
confirming a pregnancy through urinary beta-hcg assays, (8, 9) but few data on the accuracy of self-59 
testing for proteinuria in the pregnant population exist.(4) An Australian study, comparing urinary 60 
protein self-testing by 212 women in clinic, to re-testing by a single nurse, found that self-testing 61 
was practical and easily implemented, but did not include an independent reference standard.(10) 62 
Several other studies describe providing pregnant women with urine dipsticks to periodically check 63 
for protein alongside self-monitoring blood pressure, but have not formally evaluated test 64 
performance. (11-13) 65 
 66 
The aim of this study was to assess the accuracy of self-testing for proteinuria during pregnancy 67 
compared to healthcare professionals (HCPs) or automated testing with a laboratory reference 68 
standard and to explore feasibility and acceptability in a UK context.   69 
  
Methods 70 
This was a mixed methods study combining test accuracy studies and questionnaires. There were 71 
four parts comprising: 1) test accuracy study for ‘proteinuria’ (using synthetic samples to provide a 72 
range of protein levels) comparing assessment by pregnant women, HCPs and an automated reader 73 
to a laboratory reference standard; 2) self-testing of urine by pregnant women compared to testing 74 
by HCPs and a laboratory reference standard; 3) a questionnaire to participating women and HCPs 75 
and 4) an online questionnaire aiming to understand women’s experience of self-testing and 76 
opinions on its future use.  77 
 78 
Test accuracy of urinary protein testing  79 
Up to 50 pregnant women of any gestation and 50 HCPs from antenatal maternity services were 80 
selected on a convenience basis from hospital sites in Oxfordshire (John Radcliffe and Horton 81 
Hospitals, Ox) and London (St Thomas’ Hospital, STH) between November 2015 and April 2016. 82 
Following written informed consent, participants were provided with simple instructions for protein 83 
testing, synthetic protein samples and standard dipstick reagent strips (a visually read enzymatic 84 
test) (ALBUSTIX reagent strips, SIEMENS, Surrey UK). Protein solutions were prepared using bovine 85 
serum albumin (Sigma-Aldrich, Dorset, UK) in 150 mmol/L sodium chloride (Fresenius Kabi Ltd, 86 
Cheshire, UK). Sodium azide was added at a concentration of 100mg/L as a bacteriostat. Stock 87 
solutions were produced at protein concentrations equivalent to seven different dipstick readings 88 
between ‘negative’ and ‘3+’ (≥500 mg/dL). The level of protein in the samples was confirmed by 89 
repeated testing by urinary protein-creatinine ratio, (uPCR) (Supplementary Table 1). Samples were 90 
tested by participating women and HCPs using visual determination as well as using an automated 91 
reader (Clinitek Status+ Analyzer, SIEMENS, Surrey, UK) by the research team. Researchers and 92 
participants were masked to the level of protein in each sample until recruitment and testing was 93 
complete. Samples were re-tested following the study to confirm that storage and testing had not 94 
  
resulted in contamination. Ethical approval was obtained from the Northern Ireland Research Ethics 95 
Committee (15/NI/0157/HSC REC-B). 96 
 97 
Self and healthcare professional proteinuria testing compared to a PCR reference standard 98 
Thirty women, participating in a pilot study of blood pressure self-monitoring in higher-risk pregnancy, 99 
attending antenatal care in Oxfordshire additionally tested their urine for protein. (National Institute 100 
for Health Research (NIHR) Central Research Network (CRN) Portfolio number: 14151)  They used a 101 
standard testing strip for proteinuria (as above) and retained the sample, which was subsequently 102 
(same day) tested by the midwife and then sent for laboratory analysis (uPCR). Equivalent categories 103 
for testing were 0-14mg/dL (negative), 15-30mg/dL (trace), >30mg/dl (1+ or more). Ethical approval 104 
was obtained from Oxford South Central Research Ethics Committee (12/SC/0625 REC-B).  105 
 106 
Questionnaire  107 
Participants in the synthetic sample testing study above completed a short questionnaire about the 108 
potential for self-testing during pregnancy, included three closed statements and an open question 109 
asking for comments (Supplementary Figure1).  110 
 111 
Online survey 112 
An online survey (March 2106) collected information on women’s views and experiences of self-113 
testing, including multiple-choice questions and a free text section for women to comment on the 114 
idea of self-testing. A link to the survey was posted on the ‘Action on Pre-eclampsia’ (APEC) 115 
Facebook Forum, a UK charity and patient support group. Ethical approval was obtained from St 116 
Georges Research Ethics Committee (SGREC16/0005). 117 
 118 
Statistical analysis 119 
  
Data were analysed using Excel and R. Descriptive statistics were compiled from the questionnaire 120 
and survey results for questions with categorical answers. For proteinuria dipstick accuracy results, 121 
the errors of the dipstick readings were grouped into five categories (-2, -1, 0, +1, +2), representing 122 
the difference between the reading from the woman, the HCP and the automated reader 123 
respectively compared to the uPCR reference standard. (e.g. +1 error where the woman’s reading 124 
was one category above that of the uPCR).  Each participant’s test performance (pregnant woman, 125 
HCP, automated reader) was calculated across all seven samples and a mean calculated per 126 
participant to obtain sensitivity and specificity for each participant. In the case of missing data for an 127 
individual, the sensitivity and specificity were calculated using the available samples. In order to 128 
compare sensitivity and specificity per group, mean sensitivity and specificity were calculated, using 129 
a threshold for a positive result of 1+ proteinuria (as errors across this threshold were considered 130 
clinically important).(3) False positive and false negative rates were calculated and a logistic 131 
regression model was used to compare the difference between the three groups (pregnant woman, 132 
HCP, automated reader). All data were included.  133 
 134 
Questionnaire analysis 135 
Free text responses in the questionnaire and online survey were analysed using a thematic 136 
approach. The qualitative data was read multiple times by researchers (KT, LB and PM) and analysed 137 
using the ‘one sheet of paper’ (OSOP) method.(15) Themes were examined across the whole dataset 138 
and in the context of individual responses.   139 
  
Results 140 
Test accuracy study 141 
A total of 100 pregnant women and 96 HCPs performed dipstick urine testing on the seven synthetic 142 
protein samples (Supplementary Figure 2). Of the pregnant women approached, 100 of 105 (95%) 143 
agreed to participate. Participating women had a mean gestation of 31 weeks (range 9 to 41 weeks), 144 
with 21 (21%) having had raised blood pressure during their pregnancy. There were small numbers 145 
of missing data (three missed samples). The HCPs who participated included 54 (56%) midwives, 21 146 
(22%) midwife support workers and 21 (22%) doctors.  147 
 148 
Overall, the number and type of errors from pregnant women and HCPs were similar (Table 1; Figure 149 
1). There were a similar proportion of errors of potential clinical importance (Supplementary Figure 150 
2) (i.e. those around 1+ threshold (Table 1) between pregnant women (10% false negatives and 2% 151 
false positives) and HCPs (10% false negatives and 4% false positives) when compared to laboratory 152 
reference standards whereas the automated reader had fewer false negatives (4%) but more false 153 
positives (10%).  154 
 155 
There was no statistically significant differences between pregnant women and HCPs in sensitivity, 156 
specificity (p=0.45 for both), positive predictive value or negative predictive value (p=0.58 for both); 157 
however the automated reader had higher sensitivity, lower specificity, a lower positive predictive 158 
value and higher negative predictive value (p= or < 0.001 in each case, Table 2) compared to 159 
pregnant women and HCPs.  160 
 161 
Self and healthcare professional proteinuria testing compared to a PCR reference standard 162 
All 30 women who were approached agreed to self-test urine in conjunction with blood pressure 163 
self-monitoring. Four women (13%) withdrew from the study (one due to pregnancy loss) before the 164 
urine testing phase. The baseline characteristics of the participants are shown in Supplementary 165 
  
Table 2. All remaining participants provided a sample for midwife and laboratory analysis and 25/26 166 
(96%) self-tested. Of 25 comparisons of participant-read dipstick vs. HCPs, 22 (88%) were identical 167 
and three (12%) were discrepant, all between negative and trace readings with no subsequent 168 
potential impact on clinical action. Of 23 comparisons of participant-read dipsticks with uPCR (two 169 
samples were not analysed in error), 21 (91%) were identical with two (9%) discrepant results. All 170 
were between 0-15 mg/dL (negative categories) and 15-30 mg/dL (trace).  171 
 172 
Questionnaire results 173 
Of those who undertook the accuracy study, 99 (99%) pregnant women and 94 (98%) HCPs also 174 
completed a questionnaire. Of women completing the questionnaire, 95 (96%) agreed that they 175 
would be willing to check their urine at home and 89 (90%) thought it would make them feel more 176 
involved in their care. All were potentially happy to share any urine testing results with their 177 
midwife, family physician or obstetrician. There was very little discrepancy in responses between 178 
women in Oxfordshire (Ox) and London (STH). (Figure 2) 179 
 180 
Most HCPs respondents indicated that they would value self-testing by some women during their 181 
pregnancy (n=83, 88%), and thought that proteinuria self-testing alongside blood pressure self-182 
monitoring would add to usual care (n=73, 78%). However, the majority also stated that they would 183 
always repeat urinalysis if a woman had already tested her urine (n=66, 69%). (Figure 2E) 184 
 185 
Free text responses were provided by 57 (58%) pregnant women and 67 (71%) HCPs who completed 186 
the questionnaire, with similar proportions across sites (Quotes in Figure 3). Themes emerging from 187 
analysis of these responses included reassurance from testing (women), the potential for earlier 188 
detection (HCPs), potential for saving time (both) and concerns about women testing (both).  189 
 190 
  
Women were reassured by negative results and potentially saving time on trips to appointments 191 
(STH34). HCPs considered that self-testing had potential for early detection of pre-eclampsia, 192 
empowering women and saving time and money (Ox53)(Figure3).  193 
 194 
However, pregnant women and HCPs raised concerns about aptitude and suitability of women for 195 
testing. Whilst many women found the dipsticks easy to use, some were worried about their ability 196 
to read them accurately (STH 38). Several women indicated wanting access to midwives for a second 197 
opinion (STH 30). Similarly, HCPs also raised concerns around a woman's ability to read the dipsticks, 198 
their understanding of the importance of doing testing as regularly as instructed and acting on 199 
results appropriately. Some were concerned that women could fail to act on positive results (STH 200 
19), while others were concerned that self-testing might make women more anxious and more likely 201 
to present at assessment units, increasing demand on services (Ox 47). Consequently some felt self-202 
testing was only suitable for certain subgroups of women (STH 31)(Figure3).  203 
        204 
Online survey 205 
Two hundred women completed the online survey, (characteristics in Supplementary Table 3 and 206 
free text quotes Figure 4) with the majority of respondents (77%, n=152) having experienced a 207 
hypertensive disorder of pregnancy. One fifth of women (20%; n=39) had previously undertaken 208 
proteinuria self-testing (Supplementary Table 4) and most of these had found the dipsticks easy to 209 
read (87%, n=34). Women reported positive experiences of self-testing, with all agreeing that it 210 
helped them feel involved in their care, and only 10% (n=4) reporting increased anxiety levels due to 211 
proteinuria self-testing.  212 
 213 
Of 17 respondents who had previously tested, most indicated that prior experiences of pre-214 
eclampsia motivated them to test their own urine and key themes were of reassurance, saving time 215 
and empowerment. Many discussed anxiety due to previous experiences, but found reassurance 216 
  
from negative results in this setting (PT1). One woman found self-testing useful because she 217 
perceived that it was less influenced by her immediate anxiety level compared to blood pressure 218 
readings (PT2). Three women said that they were reassured by self-monitoring between scheduled 219 
antenatal appointments, and that this prevented unnecessary trips to the hospital. One woman 220 
commented on the value of a positive proteinuria result (PT3)(Figure 4). 221 
 222 
Of those women who had not experienced self-testing for proteinuria (81%, n=161), the majority 223 
(99%, n=159) said they would be willing to check their own urine for protein after training 224 
(Supplementary Table 5). The majority (97%, n=155) said that self-testing would help them feel more 225 
involved in their pregnancy care. Conversely, 26 women (17%) agreed or strongly agreed with the 226 
statement that self-testing would increase their anxiety during pregnancy (Supplementary Table 5).  227 
 228 
Women who had not tested their own urine had similar themes of reassurance and empowerment 229 
to those that had self-tested, with additional issues raised of training and HCPs’ attitudes. 230 
Reassurance appeared particularly important in those who had previous experience of pre-231 
eclampsia or hypertension (NT1) Urine testing could reduce rather than increase anxiety (NT2): 232 
Adequate training, explanation and clear instructions could also reduce any anxiety they felt (NT3). 233 
The women emphasised that it was important that HCPs were receptive to the results (NT4)(Figure 234 
4).  235 
  236 
  
Discussion  237 
Main Findings 238 
This study has shown that pregnant women and HCPs were able to test for proteinuria over a range 239 
of protein concentrations with similar levels of accuracy. As with previous research, testing by 240 
women and HCPs was less sensitive but more specific than automated testing using a reference 241 
standard of laboratory uPCR. Overall self-testing was acceptable to both pregnant women and HCPs 242 
both theoretically and alongside blood pressure self-monitoring. Self-testing was perceived as 243 
providing reassurance and convenience for women, particularly those with previous experience of 244 
hypertensive disease in pregnancy, though there were some concerns as to whether HCPs would 245 
always trust the results provided by pregnant women. Women felt that support from their HCPs 246 
would be important, perhaps reflecting the reticence of professionals to act on women’s own 247 
results.  248 
 249 
Strengths and Limitations 250 
This mixed methods study has included a relatively large number of women and HCPs who tested 251 
samples over a range of protein concentrations both on synthetic and real urine, providing 252 
comprehensive data on test accuracy. Use of synthetic urine samples ensured that sufficient 253 
numbers of positive samples were tested, and whilst the numbers testing their own urine were 254 
relatively small (n=26) and for a limited period they provided similar results and were representative 255 
of women who might be asked to undertake such testing. This suggests that it is unlikely that the 256 
accuracy of testing would be altered in a clinical vs home setting, though the experience may be. 257 
Previous pilot work of self-testing of blood pressure in pregnancy completed by this group has 258 
indicated that women found blood pressure monitoring acceptable and reassuring. Women who 259 
completed proteinuria testing in the home environment were positive about the experience but 260 
further work on the experience of regular self-testing through pregnancy is required. 261 
 262 
  
Questionnaire and online survey data gathered views from a large number of participants including 263 
currently pregnant women, those with and without experience of self-testing, women with both 264 
hypertensive and normotensive pregnancies and a variety of HCPs providing a range of experiences 265 
and opinions. The majority of online survey participants had experienced hypertensive disorders of 266 
pregnancy, and therefore those most likely to be considered for additional home testing. The survey 267 
provided both quantitative and qualitative data providing an in-depth understanding of views and 268 
experiences. The similarity between the questionnaire results of pregnant women and the online 269 
survey findings suggest broad acceptability and appeal of self-testing. 270 
 271 
Some selection bias from the online survey is possible as respondents were limited to internet users; 272 
however, most of the target population will be web connected,(16). By engaging with the charity 273 
APEC and responding to the online survey, the participants were likely to be individuals with 274 
previous experience, who had sought extra information and support, and may therefore be more 275 
motivated to adopt health behaviours such as proteinuria self-testing.  276 
 277 
Comparison with previous work  278 
There are surprisingly few data on proteinuria self-testing in the pregnant population. A 2002 279 
Australian study showed that women interpreting results in clinic had a tendency to overestimate 280 
proteinuria compared to the midwife performing the same test; the authors suggested that self-281 
testing of urine during pregnancy could be easily implemented at antenatal visits.(10)  More 282 
recently, large screening studies undertaken within the general non-pregnant population for early 283 
detection of renal disease found that self-testing improves the chances for early diagnosis and 284 
therapy, though participants tended to report false positives for proteinuria.(17, 18)  285 
 286 
There is heterogeneity in the reported sensitivity and specificity of testing with reagent strips within 287 
the literature across patient and staff groups, and limited data from studies in pregnancy. Bell et al 288 
  
used five albumin samples to look at the accuracy of testing and reported a high false positive rate 289 
for the two non-proteinuric samples (nursing auxiliaries; 40% and 55% and midwives; 5% and 30%). 290 
For the three positive samples both groups recorded false negative rates of between 10-45%.(19) 291 
While automated readers had higher sensitivity, they also produced a lower specificity, i.e. yielding 292 
more false positive results that may lead to unnecessary anxiety and additional appointments and 293 
testing for some women.(20, 21) These studies compare to false positive rates of only 2-4% in our 294 
study; the majority of false negative results related to differences between negative and trace 295 
amounts of proteinuria, and would therefore not have changed clinical action. 296 
 297 
There are no published studies to date on user experiences of proteinuria self-testing. Most of the 298 
literature on patient views and experiences of self-monitoring come from studies of blood pressure 299 
self-monitoring outside of pregnancy, which have generally found similarly positive views to results 300 
reported here. A feasibility study done in low-risk pregnant women showed a preference for blood 301 
pressure self-monitoring with a reduced schedule of antenatal visits, and no change in anxiety 302 
levels.(22) Literature on blood pressure self-monitoring outside pregnancy indicates patients are 303 
confident at self-monitoring and report high levels of satisfaction and feelings of involvement, 304 
control, and support for their health.(23) (24) In the current study similar findings for self-testing of 305 
urine are reported; women whose readings were used by HCPs felt valued and involved in their own 306 
care and reported positive experiences. Combined self-testing of blood pressure and urine could allow 307 
triggers for action based on home readings to mirror clinical diagnostic pathways for pre-eclampsia, 308 
could increase women’s confidence in findings, improve self-involvement in antenatal care and reduce 309 
additional screening visits thereby providing a cost-effective intervention. 310 
 311 
Implications for future research and clinical practice 312 
The results of this study are an important first step in considering the potential for self-monitoring 313 
for proteinuria in pregnancy. This inexpensive, simple and rapid test could improve detection of pre-314 
  
eclampsia, a potentially serious condition, and be used to reduce additional appointments required 315 
by some pregnant women (thereby alleviating burden on women and healthcare resources). Self-316 
testing was acceptable and well received in a population of women who were at increased risk of 317 
pre-eclampsia. Participants were willing and able to test for proteinuria alongside blood pressure 318 
self-monitoring during pregnancy and self-testing appears to be as accurate as testing by HCPs. A full 319 
evaluation of the impact on detection rates of proteinuria and pre-eclampsia, cost effectiveness, 320 
pregnancy outcomes and women’s experiences of regularly completing self-testing is needed before 321 
considering adopting self-monitoring more widely during pregnancy.  322 
 323 
Intended population 324 
This pilot work confirms that women at higher risk of pre-eclampsia are willing and able to complete 325 
this testing. The most suitable population for regular proteinuria self-testing may be pregnant 326 
women who have developed hypertension or those at high risk within the second half of pregnancy 327 
when pre-eclampsia is most likely to develop. 328 
 329 
Barriers 330 
While testing for urinary protein and monitoring of blood pressure are known to be of value during 331 
pregnancy, self-testing is unlikely to be suitable for all women. In addition, HCPs will need evidence 332 
to be convinced about the benefits of self-testing and require clear pathways to follow alongside 333 
current care.  334 
 335 
Conclusion 336 
This research suggests that self-testing of proteinuria is feasible, acceptable and potentially 337 
advantageous for both pregnant women and HCPs. If shown to be sufficiently accurate when tested 338 
at scale and is cost effective, proteinuria self-testing has the potential to be a valuable method of 339 
  
screening for pre-eclampsia in pregnancy, and may result in earlier diagnosis of this condition than 340 
current practice.  341 
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Table 1. Percentages of testing at different thresholds by pregnant women, health care professionals 
and automated readers. Numbers in bold represent false positive readings, figures in bold and italics 
represent false negative readings defined in each case as a misclassification, which would change 
management. 
Results are shown as a proportion of women answering to allow comparisons between groups. 
*each sample tested at least twice in each machine. 
 
Figure 1:  Protein testing results by samples and categories 
Test results are shown for 100 pregnant women (PW), 96 healthcare professionals (HCPs) and three 
automated readers. The errors of the results were grouped into five categories types (-2, -1, 0, 1, 2). 
The ‘0’ results show no error, the type 1 error are outcomes with 1 category above the correct 
answers. Check shading indicates clinically important false positive results and spotted shading 
indicates clinically important false negative results.  
 
Table 2: Group mean test accuracy of results by pregnant women, healthcare professionals and 
automated readers compared to uPCR (laboratory reference standard).  
 
Figure 2: Questionnaire responses by pregnant women (A & B) and health care professionals (C, D & 
E) who had undertaken the test accuracy study (n=99 and 94 respectively).  
 
Figure 3: Quotes from free text responses gained from the accuracy study 
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Quotes from free text responses 
“Being high risk myself I feel it would give peace of mind and less stress of running to the GP constantly to 
be able to test your urine at home” (STH 34). 
“I think that self-monitoring is very useful to save health professionals time and the women’s time in going 
to appointments. I believe it is also empowering for the women.” (Ox 53) 
“The testing procedure is simple, although the results are sometimes hard to interpret if they are ‘in 
between’ colours” (STH 38). 
“Some mums might not feel capable doing it if they are not trained and would want someone who has 
training to check it to be sure that they are getting the right answer” (STH 30). 
“I'd worry about women forgetting to do it or saying they would and making up normal results to avoid 
being high risk.” (STH 19). 
“It could cause unnecessary admittance to MAU [Maternity Assessment Unit] if women not trained 
appropriately.” (Ox 47).   
“It would depend on the women and their understanding of the importance of this testing.” (STH 31). 
 
Figure 3. Quotes from free text responses collected from the accuracy study 
  
  
Figure 4. Quotes from the free text section in the online survey 
  
Quotes from the free text section in the online survey 
PT1 “I found it hugely reassuring to be able to check this myself at home, it was empowering and took 
away the anxiety around appointments.” 
PT2 “Also knowing how nervous I was about BP (therefore how it can fluctuate sometimes with stress 
levels) I also wanted something to measure that couldn't be influenced by anxiety or stress.” 
PT3 “The dipsticks gave me the confidence to go back in [to the hospital], which was the right decision 
to make.” 
NT1 “Having got severe PET and HELLP a few hours after birth with my firstborn I know that if I have 
another I would be really anxious about it occurring in pregnancy and would feel worried in between 
antenatal check-ups so it would reassure me.” 
NT2 “During pregnancy a lot felt out of my control and waiting between midwife appointments 
sometimes left me anxious. Self-testing would make me feel like I could do something myself to take 
away some anxiety”. 
NT3 “I also agree that it may cause more anxiety for some if the reading is not clear cut, as long as 
training and reference points are clear for mothers I do believe this would be beneficial overall.” 
NT3 “GP surgeries need to be better briefed as well on this, otherwise patients could self-test and still 
the doctor ignores the signs.” 
  
Table 1. Percentages of testing at different thresholds by pregnant women, health care professionals 
and automated readers. Numbers in bold represent false positive readings, figures in bold and italics 
represent false negative readings defined in each case as a misclassification, which would change 
management. 
 




















       
Negative 97 80 6 2 0 5 0 
Trace 2 19 79 34 17 13 0 
1+ 1 1 15 62 78 67 2 
2+ 0 0 0 2 4 15 12 
3+ 0 0 0 0 1 0 82 




       
Negative 97 66 4 1 0 6 0 
Trace 3 33 72 33 15 15 0 
1+ 0 1 24 65 83 57 0 
2+ 0 0 0 1 2 22 15 
3+ 0 0 0 0 0 0 73 
4+ 0 0 0 0 0 0 12 
Automated readers 
(n=3)* 
       
Negative 100 85 0 0 0 0 0 
Trace 0 11 33 8 19 0 0 
1+ 0 4 67 81 81 33 0 
2+ 0 0 0 11 0 67 0 
3+ 0 0 0 0 0 0 100 
4+ 0 0 0 0 0 0 0 
Results are shown as a proportion of women answering to allow comparisons between groups. 
*each sample tested at least twice in each machine. 
  
Table 2: Group mean test accuracy of results by pregnant women, healthcare professionals and 
automated readers compared to uPCR (laboratory reference standard).  
 Pregnant women Healthcare 
professional 
Automated readers 
Sensitivity 0.81 (0.78-0.85) 0.83 (0.79-0.86) 0.94 (0.91-0.97) 
Specificity 0.93 (0.91-0.95) 0.92 (0.90-0.94) 0.78 (0.69-0.85) 
Positive predictive value 0.94 (0.90-0.96) 0.94 (0.91-0.95) 0.85 (0.79-0.90) 










 Healthcare professional testing and self-testing for protein had similar accuracy. 
 Self-testing was feasible and acceptable to both women and health care professionals. 
 Self-testing for protein could add to clinic-based surveillance for pre-eclampsia. 
 
